GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Tandem Diabetes Care Inc (LTS:0M0F) » Definitions » Interest Expense

Tandem Diabetes Care (LTS:0M0F) Interest Expense : $-5.0 Mil (TTM As of Mar. 2025)


View and export this data going back to 2018. Start your Free Trial

What is Tandem Diabetes Care Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Tandem Diabetes Care's interest expense for the three months ended in Mar. 2025 was $ -1.4 Mil. Its interest expense for the trailing twelve months (TTM) ended in Mar. 2025 was $-5.0 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Tandem Diabetes Care's Operating Income for the three months ended in Mar. 2025 was $ -120.9 Mil. Tandem Diabetes Care's Interest Expense for the three months ended in Mar. 2025 was $ -1.4 Mil. Tandem Diabetes Care did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.


Tandem Diabetes Care Interest Expense Historical Data

The historical data trend for Tandem Diabetes Care's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tandem Diabetes Care Interest Expense Chart

Tandem Diabetes Care Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Interest Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only -12.15 -4.31 -4.31 -8.08 -5.51

Tandem Diabetes Care Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Interest Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.43 -1.79 -1.87 0.05 -1.36

Tandem Diabetes Care Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $-5.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Tandem Diabetes Care  (LTS:0M0F) Interest Expense Explanation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense. The higher, the better.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Tandem Diabetes Care's Interest Expense for the three months ended in Mar. 2025 was $-1.4 Mil. Its Operating Income for the three months ended in Mar. 2025 was $-120.9 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Mar. 2025 was $431.8 Mil.

Tandem Diabetes Care's Interest Coverage for the quarter that ended in Mar. 2025 is calculated as

Tandem Diabetes Care did not have earnings to cover the interest expense.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's financial strength is.


Tandem Diabetes Care Business Description

Traded in Other Exchanges
Address
12400 High Bluff Drive, San Diego, CA, USA, 92130
Tandem Diabetes designs, manufactures, and markets durable insulin pumps for diabetes patients. The firm first entered this market in 2012 and has since introduced multiple generations of pumps leading to its current t:slim X2 device. The firm recently launched its smaller Mobi pump and continues to work on a tubeless pump. Nearly three-quarters of total revenue is derived from the us, with the remainder primarily from other developed nations. The pumps themselves generate just over half of total sales, and another one third is from disposable infusion sets that need to be changed over every 2 to 3 days.

Tandem Diabetes Care Headlines

No Headlines